Innovations for Changing the Face of Women’s Reproductive Health Therapeutics

At ObsEva, our passion and expertise in reproductive health and pregnancy therapeutics is helping millions of women worldwide lead healthier and more fulfilling lives.

Significant Unmet Needs in Reproductive Health

Millions of women worldwide suffer from reproductive health conditions that affect their quality of life or ability to conceive and may lead to complications during pregnancy.

Innovation From Conception to Birth and Beyond

ObsEva is advancing a robust pipeline of novel, orally-administered, clinical-stage compounds in the areas of uterine fibroids, endometriosis, assisted reproductive technology, and preterm labor.

Recent Updates

08 Nov 2018

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

Read more
07 Nov 2018

ObsEva SA to Participate in November Investor Conferences

Read more
31 Oct 2018

ObsEva SA to Hold Third Quarter 2018 Financial Results and Business Update Call on November 8, 2018

Read more
09 Oct 2018

ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting

Read more